Aclarion, Inc. (ACON)
ACONNASDAQ-CMMedical Specialities
$1.66
-0.0900 (-5.14%) today
At the close, Nov 10, 4:00 PM ET. After hours $1.60 –
- Market cap
- $4.61m
- P/E
- –
- EPS, last 4 quarters
- $-7.40
- Dividend yield
- –
- Day range
- $1.60 to $1.75
- 52-week range
- $1.54 to $9.36
- Average volume
- 32.5k
- Previous close
- $1.75
Earnings
next estimate $-1.05Next report Nov 11, 2026
Sep 2025
-11.0%
Dec 2025
+44.2%
Mar 2026
+13.6%
Jun 2026
-6.7%
estimate reported, and the surprise
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | $19.0k | $18.0k | $21.0k | $25.0k |
| Gross profit | $4,000 | $2,000 | $4,000 | $8,000 |
| Operating income | -$1.83m | -$1.99m | -$2.99m | -$2.90m |
| Net income | -$1.71m | -$1.89m | -$2.85m | -$2.75m |
Last four quarters: revenue $83.0k, margin -11080.7%, free cash flow –
News
8 latest- DocGo Inc. (DCGO) Reports Q3 Loss, Lags Revenue EstimatesZacks · 1 day ago
- Sonida Senior Living (SNDA) Reports Q3 Loss, Lags Revenue EstimatesZacks · 5 days ago
- Ardent Health, Inc. (ARDT) Beats Q3 Earnings and Revenue EstimatesZacks · 6 days ago
- Bausch + Lomb (BLCO) Surpasses Q3 Earnings and Revenue EstimatesZacks · Oct 28, 2026
- HCA Healthcare (HCA) Q3 Earnings and Revenues Top EstimatesZacks · Oct 27, 2026
- Aclarion Updates CLARITY Enrollment Criteria, Keeps Trial Timeline On Track RTTNews · Oct 8, 2026
- Aclarion, Inc. (ACON) Reports Q2 Loss, Lags Revenue EstimatesZacks · Aug 6, 2026
- Sotera Health Company (SHC) Beats Q2 Earnings and Revenue EstimatesZacks · Aug 6, 2026
The company
Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy ('MRS'), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan, the first, evidence-supported, SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. Biomarker data is entered into proprietary algorithms to indicate if a disc may be a source of pain.
- Sector
- Health Care
- Industry
- Medical Specialities
- Exchange
- NASDAQ-CM
- Region
- North America
- Website
- aclarion.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.